Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oric Pharmaceuticals (ORIC) Cash & Current Investments (2019 - 2026)

Oric Pharmaceuticals filings provide 8 years of Cash & Current Investments readings, the most recent being $281.9 million for Q1 2026.

  • Quarterly Cash & Current Investments rose 38.39% to $281.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $281.9 million through Mar 2026, up 38.39% year-over-year, with the annual reading at $281.5 million for FY2025, 9.97% up from the prior year.
  • Cash & Current Investments hit $281.9 million in Q1 2026 for Oric Pharmaceuticals, roughly flat from $281.5 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $316.8 million in Q1 2024 and bottomed at $189.6 million in Q1 2023.
  • Average Cash & Current Investments over 5 years is $248.2 million, with a median of $256.0 million recorded in 2024.
  • The largest annual shift saw Cash & Current Investments skyrocketed 67.05% in 2024 before it plummeted 35.69% in 2025.
  • Oric Pharmaceuticals' Cash & Current Investments stood at $206.3 million in 2022, then rose by 0.93% to $208.2 million in 2023, then increased by 22.95% to $256.0 million in 2024, then rose by 9.97% to $281.5 million in 2025, then grew by 0.16% to $281.9 million in 2026.
  • Per Business Quant, the three most recent readings for ORIC's Cash & Current Investments are $281.9 million (Q1 2026), $281.5 million (Q4 2025), and $287.1 million (Q3 2025).